Skov, J. K., Sikandar, U., Bonnesen, K., Poulsen, S. H. & Schmidt, M. (2026).
Validity of Amyloidosis in the Danish National Patient Registry.
Clinical epidemiology,
18, 1-8. Article 546761.
https://doi.org/10.2147/CLEP.S546761
Shumilov, E., Ngoya, M., Berning, P., Devillier, R., Forcade, E., Schroeder, T., Kroschinsky, F., Stelljes, M., Valkova, V., Kinsella, F., Chevallier, P.
, Olesen, G., Mohty, M., de Fontbrune, F. S., Wagner-Drouet, E., Zeiser, R., Herling, M., Franke, G. N., López-Corral, L. ... Schmitz, N. (2026).
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party.
Journal of Hematology and Oncology,
19(1), Article 17.
https://doi.org/10.1186/s13045-026-01783-wOgunjimi, B., Warren-Gash, C., Ouwendijk, W. J. D., Breuer, J.
, Mogensen, T. H. & Koelle, D. M. (2026).
Varicella zoster virus and the central nervous system.
Nature Reviews Microbiology. Advance online publication.
https://doi.org/10.1038/s41579-026-01289-9Joseph, J. V., Blaavand, M. S., Kelstrup, G. W.
, Rasmussen, S. A., Cai, H., Vendelbo, M. & Thomsen, M. K. (2026).
A syngeneic glioblastoma mouse model with mesenchymal hallmarks.
Neuroscience,
600, 26-33.
https://doi.org/10.1016/j.neuroscience.2026.02.018
Patabendige, S., Harders, S. M. W.
, Bendstrup, E., Durheim, M. T., Laursen, C. B., Andersen-Ranberg, K., Brockhattingen, K. K., Kildegaard, C., Bendixen, M. & Davidsen, J. R. (2026).
Rationale and design of uLtrasOund applicability in the assessment of patients with fibRosing interstitial lung Disease (LORD): a research protocol of a prospective cohort study.
BMJ Open,
16(2), e112171.
https://doi.org/10.1136/bmjopen-2025-112171Garcés de Marcilla Lappin, I., Mana, L., Aleman-Gomez, Y., Alameda, L., Solida, A., Jenni, R., Baumann, P. S., Klauser, P., Conus, P.
, Kringelbach, M., Hagmann, P., Deco, G. & Sanz Perl, Y. (2026).
Perturbations of whole-brain model reveal critical areas related to relapse of early psychosis.
Network Neuroscience,
10(1), 62-79.
https://doi.org/10.1162/NETN.a.502Bolla, E., Semb, A. G., Petri, M., Sfikakis, P. P., Artim-Esen, B., Hernandez-Molina, G., Hachulla, E., Direskeneli, H., Karpouzas, G. A., Zucchi, D., Goyal, M., Costedoat-Chalumeau, N., Tincani, A., Yazici, A., Lerang, K.
, Troldborg, A., Ajeganova, S., Popkova, T. V., Svenungsson, E. ... Yilmaz, E. (2026).
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries.
The Lancet Rheumatology,
8(3), e192-e203.
https://doi.org/10.1016/S2665-9913(25)00257-7Stensland, E. M.
, Stensgaard, S., Eide, I. J. Z., Nilssen, Y., Horndalsveen, H., Cicenas, S., Grønberg, B. H., Ekman, S., Hansen, K. H.
, Sorensen, B. S. & Brustugun, O. T. (2026).
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).
Lung Cancer,
214, Article 109338.
https://doi.org/10.1016/j.lungcan.2026.109338